ClinicalTrials.gov record NCT07702149

Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus

Record copied from ClinicalTrials.gov: Oct 10, 2026AI summaries generated: Sep 16, 2026

Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus

StatusRecruitingThe study is currently enrolling participants. Only the study team can say whether a particular person can join.
Study typeInterventionalA study in which researchers assign participants to one or more interventions, such as a drug, procedure, device, behavioural programme or other approach, to measure their effects.
Age40 years old to 55 years old
SexAll
LocationEgypt
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

This randomized study compares a 12-week low-calorie diet with a waitlist in 40 people who have Behcet disease, obesity, and subjective tinnitus. Twenty participants follow a 12-week low-calorie diet and twenty are on a waitlist without intervention. Tinnitus measures and several related questionnaires and body measurements are assessed after 12 weeks.

What it is studying. The study tests the effects of a 12-week low-calorie diet versus a waitlist on tinnitus severity and tinnitus-related quality of life, plus mood, sleep, and body measurements in people with Behcet disease and obesity.

What the researchers hope to learn. Scientific goal: to evaluate whether a 12-week low-calorie diet changes tinnitus handicap scores and other outcomes measured after 12 weeks, including tinnitus severity and distress, anxiety and depression measures, sleep, waist circumference, body mass index, and Behcet disease–related quality of life.

What this study is about

The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.

otogic problems are varied in bechet disorder, tinnnitus is one of these problems. obesity may increase this probelm

Interventions being studied

Being studied in this trial does not mean the treatment or procedure is approved or available for this condition.

Behavioral
  • diet restriction

Eligibility

The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.

Inclusion criteria

  • behcet disease
  • obesity
  • subjective tinnitus (bilateral)

Exclusion criteria

  • other autoimune diseases
  • refusal to participate

Study description and what participation involves

The study's detailed description, as published on ClinicalTrials.gov.

Detailed description from the registry

Forty subjects with behcet disorder, excess weight, complaint o tinnnitus will divided to group I or group II. low caorie diet 12-week regeim wil be followed by 20-patient group I . the 20-patient group II will be waitlist.

AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

Participants are randomly assigned to one of two groups: 20 people follow a 12‑week low‑calorie diet and 20 are placed on a waitlist with no intervention during that time. Those in the diet group follow the prescribed low‑calorie regimen for 12 weeks; the waitlist group does not receive the diet during the study period. After 12 weeks the study collects tinnitus-related questionnaires (for example the Tinnitus Handicap Inventory, visual analog scales, and the Tinnitus Reaction Scale), psychological questionnaires (anxiety, depression, life satisfaction, insomnia), and physical measurements (waist circumference and body mass index). The trial is randomized and single-masked and includes a total of 40 participants divided into two groups of 20.

How the study is structured. Interventional, randomized, parallel assignment. Forty participants are randomly assigned to one of two groups: a 12-week low-calorie diet group (20 people) or a waitlist group (20 people). The study uses single masking. Key outcomes are measured after 12 weeks.

Questions you could ask

These questions are suggestions for a conversation with the study team or your own clinician, not advice.

  • The registry lists this study under Behcet Disease; Obesity; Subjective Tinnitus. Does it apply to my diagnosis?
  • The listed sites are in Egypt. Is any of them reachable for me, and does the study help with travel?
  • Which of the eligibility criteria would need to be checked with tests before I could join?

More on Behçet's disease

This trial is also listed on this site under familial Mediterranean fever.

Clinical trials34 trials listed for Behçet's diseaseEvery trial the registry lists for Behçet's disease, with recruitment status, phase and sites, updated from ClinicalTrials.gov.See all trials →Research updatesWhat changed in Behçet's disease researchLatest monthly update: September 2026. Includes: Low-dose IL-2 trial. New research summarized each month in plain language, with links to every source paper.Read the latest update →

Important dates

Study start
Jun 4, 2026
Primary completion
Sep 10, 2026 (estimated)
Study completion
Sep 10, 2026 (estimated)
Target enrollment
40 participants (estimated)
Last updated on registry
Jul 14, 2026
Data verified
Oct 10, 2026

Sponsor and research team

The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.

Lead sponsor
Cairo University
Principal investigator
Ali Mohamed Ali ismail, lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University
Cairo University

Central study contact

If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.

Participating sites (2)

Terms used on this page · explanations by MedicalUpdates.ai

Inclusion Criteria
The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
Exclusion Criteria
The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.

The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.

← Back to clinical trials